May 15, 2017 9:00 am
On 11 May 2017, the Ministry of Health (MoH) of DRC informed WHO that of the five samples collected from suspected cases, one tested positive by RT-PCR for Ebola virus subtype Zaire at the Institut National de Recherche Biomédicale (INRB) in Kinshasa. Additional specimens are currently being tested and results, including sequencing, are awaited to describe the outbreak.
April 19, 2017 9:00 am
Neglected tropical diseases affect roughly 1 billion people worldwide and kill about 534,000 each year, according to the US Centers for Disease Control and Prevention (CDC). But drug companies and science agencies in rich countries tend to ignore these maladies because they almost exclusively afflict the world’s poorest people.
March 31, 2017 9:00 am
The European Patent Office (EPO) announced on 23 March its “intention to grant a patent” to the University of California (UC) for its broad-based claims about the genome-editing tool popularly known as CRISPR. UC, on behalf of several parties, has been in a pitched battle with the Broad Institute of Cambridge, Massachusetts, over CRISPR patents, and the new decision marks a sharp departure from the position of the U.S. Patent and Trademark Office (USPTO).
March 23, 2017 9:00 am
The San people of Southern Africa are among the closest living relatives of our hunting and gathering ancestors. Scientists have flocked to study their age-old rituals and ancient genetic fingerprints. Now, after more than a century of being scrutinized by science, the San are demanding something back. Earlier this month the group unveiled a code of ethics for researchers wishing to study their culture, genes, or heritage.
March 9, 2017 9:00 am
China’s central government is laying plans to curb pollution, increase food and drug safety, and boost scientific research—though supporting details are scarce.
Chinese Premier Li Keqiang outlined these and other major goals during the opening session of the National People’s Congress on Sunday. The congress discussions are not likely to result in new legislation specific to science but speeches by top leaders set the tone for policy over the coming year.
“Having reached the current stage of development, China can now advance only through reform and innovation,” Li said in support of his call to boost research efforts. China has “the largest pool of scientists, engineers, and professionals in the world, and their potential for innovation is truly tremendous.”
March 1, 2017 9:00 am
Global funding for research on neglected diseases — which include tuberculosis, HIV/AIDS and malaria — is at its lowest level since 2007, according to the annual G-FINDER investment report by Policy Cures Research, a health-policy analysis firm in Sydney, Australia.
February 17, 2017 9:00 am
An old steroid treatment, long available outside the United States, received approval this week for a rare disease that afflicts about 15,000 Americans. Though not previously approved in the United States, the drug, deflazacort, has for years been available to patients suffering from the devastating and fatal disease Duchenne muscular dystrophy; families can import it from abroad for about $1,200 per year on average. The new list price for the drug? $89,000 a year.
February 9, 2017 9:00 am
A group backed by the Bill & Melinda Gates Foundation that works on India’s immunization program will now be funded by the health ministry, a government official said, a move in part prompted by fears foreign donors could influence policy making.
January 31, 2017 9:00 am
Clearly, private companies cannot be expected to invest on their own. But it is incumbent on governments to invest, and thus address this market failure, in partnership with pharma. It is therefore encouraging that there is now a solid plan to do just that: the Coalition for Epidemic Preparedness Innovations (CEPI), launched on 18 January at the World Economic Forum in Davos, Switzerland, aims to develop and take through early clinical trials vaccines against potential threats. It already has enough cash to work on three — MERS, Nipah-virus infection and Lassa fever.